Impact of a genomic classifier of metastatic risk on postoperative treatment recommendations for prostate cancer patients: a report from the DECIDE study group

BACKGROUND: Only a minority of prostate cancer patients with adverse pathology and biochemical recurrence (BCR) post radical prostatectomy (RP) experience metastasis and die from prostate cancer. Improved risk prediction models using genomic information may enable clinicians to better weigh the risk...

Descripción completa

Detalles Bibliográficos
Autores principales: Badani, Ketan, Thompson, Darby J. S., Buerki, Christine, Davicioni, Elai, Garrison, Jill, Ghadessi, Mercedeh, Mitra, Anirban P., Wood, Penelope J., Hornberger, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2013
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3720607/
https://www.ncbi.nlm.nih.gov/pubmed/23592338

Ejemplares similares

Ejemplares similares